DALY II USA/ MB-CART2019.1 for DLBCL
Public ClinicalTrials.gov record NCT04792489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects With Relapsed and/or Refractory Diffuse Large B Cell Lymphoma
Study identification
- NCT ID
- NCT04792489
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Miltenyi Biomedicine GmbH
- Industry
- Enrollment
- 248 participants
Conditions and interventions
Conditions
Interventions
- Bendamustine Drug
- Cyclophosphamide Drug
- Fludarabine Drug
- zamtocabtagene autoleucel (MB-CART2019.1) Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 24, 2021
- Primary completion
- Dec 30, 2026
- Completion
- Dec 30, 2028
- Last update posted
- Apr 23, 2025
2021 – 2028
United States locations
- U.S. sites
- 23
- U.S. states
- 19
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | Recruiting |
| Mayo Clinic | Phoenix | Arizona | 85054 | Recruiting |
| UC San Diego Health | La Jolla | California | 92037 | Recruiting |
| Stanford University | Stanford | California | 94305 | Recruiting |
| Yale University | New Haven | Connecticut | 06520 | Recruiting |
| Baptist Health Miami Cancer Institute | Miami | Florida | 33176 | Recruiting |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | Recruiting |
| Georgia Cancer Center at Augusta University | Augusta | Georgia | 30912 | Recruiting |
| Robert H Lurie Cancer Center | Chicago | Illinois | 60611 | Recruiting |
| University of Kansas Cancer Center | Westwood | Kansas | 66205 | Recruiting |
| University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center | Baltimore | Maryland | 21201 | Recruiting |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Recruiting |
| University of Michigan | Ann Arbor | Michigan | 48109 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | Terminated |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Recruiting |
| Duke University Medical Center - Division of Hematologic Malignancies | Durham | North Carolina | 27705 | Recruiting |
| The Ohio State University Wexner Medical Center James Cancer | Columbus | Ohio | 43210 | Recruiting |
| Oregon Health and Science University Knight Cancer Institute | Portland | Oregon | 97239 | Recruiting |
| Allegheny Health Network Cancer Institute | Pittsburgh | Pennsylvania | 15212 | Recruiting |
| University of Pittsburgh - Hillman Cancer Center | Pittsburgh | Pennsylvania | 15260 | Withdrawn |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | Recruiting |
| Froedtert Hospital and the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04792489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04792489 live on ClinicalTrials.gov.